Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, WHO Collaborating Centre for Pharmaceutical Policy and Regulation, PO Box 80 082, 3508 TB, Utrecht, The Netherlands.
Faculty of Health, York University, Toronto, ON, Canada.
Sci Eng Ethics. 2019 Aug;25(4):1167-1192. doi: 10.1007/s11948-018-0041-5. Epub 2018 May 2.
Many factors contribute to the inappropriate use of medicines, including not only a lack of information but also inaccurate and misleading promotional information. This review examines how the promotion of pharmaceuticals directly affects the prescribing and use of medicines. We define promotion broadly as all actions taken directly by pharmaceutical companies with the aim of enhancing product sales. We look in greater detail at promotion techniques aimed at prescribers, such as sales representatives, pharmaceutical advertisements in medical journals and use of key opinion leaders, along with the quality of information provided and the effects thereof. We also discuss promotion to the public, through direct-to-consumer advertising, and its effects. Finally, we consider initiatives to regulate promotion that come from industry, government and nongovernmental organizations.
许多因素导致了药品的不当使用,不仅包括信息不足,还包括不准确和误导性的促销信息。本综述考察了药品促销如何直接影响处方和药品的使用。我们将促销广义地定义为制药公司为了提高产品销售额而采取的所有直接行动。我们更详细地研究了针对处方医生的促销技巧,如销售代表、医学期刊上的药品广告和利用关键意见领袖,以及所提供信息的质量和影响。我们还讨论了通过直接面向消费者的广告向公众进行促销及其影响。最后,我们考虑了来自行业、政府和非政府组织的监管促销的举措。